Oct 10 (Reuters) - Sanara Medtech Inc SMTI.O :
* SANARA MEDTECH ANNOUNCES FIRST SALE OF ALLOCYTE® PLUS
ADVANCED
VIABLE BONE MATRIX AND PROVIDES OTHER PRODUCT UPDATES
* SANARA MEDTECH INC - COMMERCIAL LAUNCH FOR BIASURGE IS
SCHEDULED
FOR NOVEMBER 2023
* SANARA MEDTECH - HAS SUFFICIENT SUPPLY OF ALLOCYTE PLUS TO
MEET
EXPECTED DEMAND & HAS ORDERS IN PLACE TO BE ABLE TO REGULARLY
STOCK PRODUCT IN FUTURE
Source text for Eikon: ID:nGNX5hQDv6
Further company coverage: SMTI.O
((Reuters.Briefs@thomsonreuters.com))